Poor clinical outcomes and immunoevasive contexture in interleukin-9 abundant muscle-invasive bladder cancer.
Zhou Q, Zhang H, Wang Z, Zeng H, Liu Z, Huang Q, Lin Z, Qu Y, Xiong Y, Wang J, Chang Y, Bai Q, Xia Y, Wang Y, Liu L, Dai B, Guo J, Zhu Y, Xu L, Xu J.
Zhou Q, et al. Among authors: zhu y.
Int J Cancer. 2020 Dec 15;147(12):3539-3549. doi: 10.1002/ijc.33237. Epub 2020 Aug 20.
Int J Cancer. 2020.
PMID: 32734613
Free article.